Travo-Vision SDU 40 ug / ml
Travo-Vision SDU 40 ug / ml is a medicine authorised by Swissmedic under authorisation number 69430. The authorisation holder is OmniVision AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 01 December 2023 and the authorisation is limited until 30 November 2028. ATC code S01EE04 places the medicine in the group Ophthalmologicals.
| Authorisation number | 69430 |
|---|---|
| Name | Travo-Vision SDU 40 ug / ml |
| Full name | Travo-Vision SDU 40 ug / ml, Augentropfen im Einzeldosisbehältnis |
| Authorisation holder | OmniVision AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01EE04 |
| First authorisation | 01 December 2023 |
| Authorisation validity | 30 November 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Travo-Vision SDU 40 ug / ml, Augentropfen im Einzeldosisbehältnis | B | 01 December 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 x 0.2 ml | Einzeldose(n) | S01EE04 | 11.09.0. | B |
| 2 | 90 x 0.2 ml | Einzeldose(n) | S01EE04 | 11.09.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Travo-Vision SDU 40 ug / ml authorised in Switzerland?
Yes. Travo-Vision SDU 40 ug / ml is authorised by Swissmedic under authorisation number 69430, data as of 01 September 2026. The authorisation is limited until 30 November 2028.
Which dispensing category does Travo-Vision SDU 40 ug / ml have?
Travo-Vision SDU 40 ug / ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Travo-Vision SDU 40 ug / ml?
The authorisation holder is OmniVision AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.